Stroke imaging specialist RapidAI hires new CEO

RapidAI, a leading neurovascular and cardiac imaging specialist, has hired Karim Karti as its new chief executive officer, the firm said Monday.

Karti has more than 25 years of experience leading medical technology companies, including 22 years at GE Healthcare Imaging, where he served as president and CEO. He also worked as chief operating officer for iRhythm Technologies, a San Francisco-based company focused on cardiac monitoring and artificial intelligence solutions.

“I am proud and humbled to join … the whole team at RapidAI in their mission to improve the diagnosis and treatment of life-threatening conditions,” Karti said in an announcement. “I look forward to bringing my own experience in imaging, artificial intelligence and digital health to help push the boundaries of clinical technology and patient care even further and continue to save lives.”

RapidAI, based in Menlo Park, California, has received multiple Food and Drug Administration clearances for its automated imaging platforms, including a tool used to spot suspected large vessel occlusions and another machine learning system that improves stroke care. The former received New Technology Add-on Payment approval from CMS back in 2020.  

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.